{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:47:39Z","timestamp":1780415259148,"version":"3.54.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022XD010"],"award-info":[{"award-number":["2022XD010"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8200111126"],"award-info":[{"award-number":["8200111126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172628"],"award-info":[{"award-number":["82172628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974371"],"award-info":[{"award-number":["81974371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173048"],"award-info":[{"award-number":["82173048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["20ZR1435200"],"award-info":[{"award-number":["20ZR1435200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["20ZR1435600"],"award-info":[{"award-number":["20ZR1435600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cellsig.2023.110710","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T11:13:50Z","timestamp":1683371630000},"page":"110710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis"],"prefix":"10.1016","volume":"108","author":[{"given":"Chen","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuer","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2023.110710_bb0005","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110710_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"43","key":"10.1016\/j.cellsig.2023.110710_bb0015","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","article-title":"Gallbladder carcinoma: prognostic factors and therapeutic options","volume":"21","author":"Goetze","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdn533","article-title":"Epidemiology of biliary tract cancers: an update","volume":"20","author":"Randi","year":"2009","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0025","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2023.110710_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1532835","article-title":"Gallbladder carcinoma in the United States: a population based clinical outcomes study involving 22,343 patients from the surveillance, epidemiology, and end result database (1973\u20132013)","volume":"2017","author":"Lau","year":"2017","journal-title":"HPB Surg."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12029-017-0036-5","article-title":"Staging, treatment, and future approaches of gallbladder carcinoma","volume":"49","author":"Shukla","year":"2018","journal-title":"J. Gastrointest. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/cco.2019.08.14","article-title":"Systemic therapy for gallbladder cancer","volume":"8","author":"Javle","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2013.2913","article-title":"Epigenetic regulation and cancer (review)","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166583","article-title":"Blood-based DNA methylation signatures in cancer: a systematic review","volume":"1869","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"24","key":"10.1016\/j.cellsig.2023.110710_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246171","article-title":"Single-cell DNA methylation analysis in cancer","volume":"14","author":"O\u2019Neill","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5532","key":"10.1016\/j.cellsig.2023.110710_bb0060","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.1063852","article-title":"The role of DNA methylation in mammalian epigenetics","volume":"293","author":"Jones","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016080","article-title":"Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer","volume":"6","author":"Radpour","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccr.2012.03.045","article-title":"DNA methylation screening identifies driver epigenetic events of cancer cell survival","volume":"21","author":"De Carvalho","year":"2012","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2017.04.005","article-title":"CHD4 has oncogenic functions in initiating and maintaining epigenetic suppression of multiple tumor suppressor genes","volume":"31","author":"Xia","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer","volume":"9","author":"Vogelstein","year":"1993","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1868-7083-4-11","article-title":"DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer","volume":"4","author":"Letelier","year":"2012","journal-title":"Clin. Epigenetics"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0090","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/hep.31585","article-title":"Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer","volume":"73","author":"Br\u00e4gelmann","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc3877","article-title":"The RUNX family: developmental regulators in cancer","volume":"15","author":"Ito","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0959-437X(03)00007-8","article-title":"RUNX transcription factors as key targets of TGF-beta superfamily signaling","volume":"13","author":"Ito","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110710_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2008.08.004","article-title":"RUNX3 attenuates beta-catenin\/T cell factors in intestinal tumorigenesis","volume":"14","author":"Ito","year":"2008","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.cellsig.2023.110710_bb0110","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","article-title":"Runx2 transcriptional activation of Indian hedgehog and a downstream bone metastatic pathway in breast cancer cells","volume":"68","author":"Pratap","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110710_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm1716","article-title":"Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation","volume":"14","author":"Hilton","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/bjc.1996.76","article-title":"Deletion mapping on chromosome 1p in well-differentiated gastric cancer","volume":"73","author":"Ezaki","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6602073","article-title":"Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer","volume":"91","author":"Matsumoto","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110710_bb0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A","article-title":"Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers","volume":"28","author":"Nomoto","year":"2000","journal-title":"Genes Chromosom. Cancer"},{"issue":"50","key":"10.1016\/j.cellsig.2023.110710_bb0135","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1038\/onc.2017.290","article-title":"Runx3 plays a critical role in restriction-point and defense against cellular transformation","volume":"36","author":"Chi","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0140","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/s41467-019-09810-w","article-title":"RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.cellsig.2023.110710_bb0145","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1158\/0008-5472.CAN-05-1647","article-title":"RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrurol.2013.89","article-title":"DNA methylation-based biomarkers in bladder cancer","volume":"10","author":"Kandimalla","year":"2013","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050717","article-title":"RUNX3 meets the ubiquitin-proteasome system in cancer","volume":"12","author":"Toska","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110710_bb0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ymthe.2022.12.009","article-title":"Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/ijbs.55636","article-title":"DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163\/TOP2A and activating Wnt\/\u03b2-catenin pathway","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110710_bb0170","first-page":"1583","article-title":"Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length","volume":"24","author":"Fathi","year":"2021","journal-title":"Iran J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/hmg\/ddy383","article-title":"Identification of the novel Ido1 imprinted locus and its potential epigenetic role in pregnancy loss","volume":"28","author":"Spinelli","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellsig.2023.110710_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215862","article-title":"LncRNA MNX1-AS1 sustains inactivation of hippo pathway through a positive feedback loop with USP16\/IGF2BP3 axis in gallbladder cancer","volume":"547","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2023.110710_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2022.03.002","article-title":"TIGAR drives colorectal cancer ferroptosis resistance through ROS\/AMPK\/SCD1 pathway","volume":"182","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"6880","key":"10.1016\/j.cellsig.2023.110710_bb0190","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/416552a","article-title":"DNMT1 and DNMT3b cooperate to silence genes in human cancer cells","volume":"416","author":"Rhee","year":"2002","journal-title":"Nature"},{"issue":"6664","key":"10.1016\/j.cellsig.2023.110710_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/34675","article-title":"The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control","volume":"391","author":"Garkavtsev","year":"1998","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.cellsig.2023.110710_bb0200","first-page":"4890","article-title":"The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2","volume":"62","author":"Leung","year":"2002","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021065","article-title":"The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination","volume":"6","author":"Thalappilly","year":"2011","journal-title":"PLoS One"},{"issue":"7545","key":"10.1016\/j.cellsig.2023.110710_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccr.2013.10.003","article-title":"Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma","volume":"24","author":"Lee","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","article-title":"Causal relationship between the loss of RUNX3 expression and gastric cancer","volume":"109","author":"Li","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0230","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41418-019-0379-5","article-title":"RUNX3 suppresses metastasis and stemness by inhibiting hedgehog signaling in colorectal cancer","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0235","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-1119(01)00760-0","article-title":"The RUNX3 gene--sequence, structure and regulated expression","volume":"279","author":"Bangsow","year":"2001","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/labinvest.3700060","article-title":"Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma","volume":"84","author":"Kim","year":"2004","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/emm.2005.37","article-title":"Hypermethylation of the RUNX3 gene in hepatocellular carcinoma","volume":"37","author":"Park","year":"2005","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0250","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41418-020-00647-1","article-title":"RUNX3 methylation drives hypoxia-induced cell proliferation and antiapoptosis in early tumorigenesis","volume":"28","author":"Lee","year":"2021","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0255","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/hep.31585","article-title":"Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer","volume":"73","author":"Bragelmann","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0260","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng1296-415","article-title":"Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation","volume":"14","author":"Garkavtsev","year":"1996","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.cellsig.2023.110710_bb0265","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1007\/s00018-013-1270-z","article-title":"ING1 and ING2: multifaceted tumor suppressor genes","volume":"70","author":"Guerillon","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"37","key":"10.1016\/j.cellsig.2023.110710_bb0270","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1038\/sj.onc.1202905","article-title":"Suppression of ING1 expression in sporadic breast cancer","volume":"18","author":"Toyama","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0275","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<118::AID-AJH11>3.0.CO;2-X","article-title":"Decreased expression of p33ING1 mRNA in lymphoid malignancies","volume":"62","author":"Ohmori","year":"1999","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0280","first-page":"811","article-title":"Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas","volume":"12","author":"Takahashi","year":"2004","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110710_bb0285","first-page":"1255","article-title":"A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis","volume":"57","author":"Helbing","year":"1997","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110710_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.321","article-title":"ING1 induces apoptosis through direct effects at the mitochondria","volume":"4","author":"Bose","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110710_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1349-7006.2007.00650.x","article-title":"Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1","volume":"99","author":"Nagahama","year":"2008","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110710_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043671","article-title":"ING1 and 5-azacytidine act synergistically to block breast cancer cell growth","volume":"7","author":"Thakur","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0305","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0002-9440(10)63679-6","article-title":"Gene discovery in bladder cancer progression using cDNA microarrays","volume":"163","author":"Sanchez-Carbayo","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.cellsig.2023.110710_bb0310","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tibs.2007.08.006","article-title":"After a decade of study-ING, a PHD for a versatile family of proteins","volume":"32","author":"Soliman","year":"2007","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110710_bb0315","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/carcin\/bgi011","article-title":"Epigenetic and genetic alterations of p33ING1b in ovarian cancer","volume":"26","author":"Shen","year":"2005","journal-title":"Carcinogenesis"},{"issue":"6664","key":"10.1016\/j.cellsig.2023.110710_bb0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/34675","article-title":"The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control","volume":"391","author":"Garkavtsev","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110710_bb0325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/excr.2002.5610","article-title":"p33(ING1) enhances UVB-induced apoptosis in melanoma cells","volume":"279","author":"Cheung","year":"2002","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0330","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an Iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0335","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2023.110710_bb0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0345","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of Ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110710_bb0350","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110710_bb0355","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110710_bb0360","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2023.110710_bb0365","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote Tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.cellsig.2023.110710_bb0370","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"issue":"6486","key":"10.1016\/j.cellsig.2023.110710_bb0375","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","article-title":"Cysteine depletion induces pancreatic tumor ferroptosis in mice","volume":"368","author":"Badgley","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2023.110710_bb0380","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2021.04.007","article-title":"SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition","volume":"510","author":"Liu","year":"2021","journal-title":"Cancer Lett."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:24:08Z","timestamp":1777580648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":76,"alternative-id":["S0898656823001249"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110710","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110710"}}